Table 7.
Multivariate analyses of clinical and tumor factors associated with Epcam in 39 HCC patients
| Variable | P value | OR | 95%CI |
|---|---|---|---|
|
Differentiation (well/moderate/poor) |
0.056 |
5.01 |
0.96-26.21 |
| TACE Treatment/not | 0.025 | 5.88 | 1.25-27.80 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.